Nonetheless, the fact that almost two-thirds of the patients had some level of IgM autoantibody recognizing cardiac proteins suggests that severe COVID-19 is a powerful inducer of heart-targeting autoantibody production. This evidence concerns the gene CD40LG and COVID-19.